SCHEMBL6237655

SCHEMBL6237655

CC(C)(C)OC(=O)NCC[C@H](O)c1cccc(F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 2/20 0.45
CTSK P43235 2/20 0.45
NQO2 P16083 1/20 0.42
MEN1 O00255 1/20 0.42
GAA P10253 1/20 0.42
KMT2A Q03164 1/20 0.42
MALT1 Q9UDY8 1/20 0.41
BRD4 O60885 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
KCNA5 P22460 1/20 0.39
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
IDO1 P14902 2/20 0.39
LMNA P02545 2/20 0.38
TSHR P16473 2/20 0.38
PPARG P37231 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25496760 0.94 MEN1 (0.50) CTSSCTSKNQO2MEN1GAA
SCHEMBL17735443 0.86 POLB (0.45) CTSSCTSKNQO2MEN1GAA
SCHEMBL16031480 0.86 NQO2 (0.51) CTSSCTSKNQO2MEN1GAA
SCHEMBL3137524 0.86 NQO2 (0.43) CTSSCTSKNQO2MEN1GAA
SCHEMBL16079975 0.86 POLB (0.45) CTSSCTSKNQO2MEN1GAA
SCHEMBL2204205 0.86 NQO2 (0.51) CTSSCTSKNQO2MEN1GAA
SCHEMBL20764686 0.85 PNMT (0.49) CTSSCTSKNQO2CES2ALDH1A1
SCHEMBL232723 0.85 CTSS (0.45) CTSSCTSKNQO2MEN1GAA
SCHEMBL10318009 0.85 KDM4E (0.46) NQO2MEN1GAAKMT2AMALT1
SCHEMBL236645 0.85 NQO2 (0.42) CTSSCTSKNQO2MEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1539695-A1 N-4-PIPERIDINYL COMPOUNDS AS CCR5 MODULATORS AstraZeneca AB (SE) 2005-06-15 EP disclosed
EP-1490336-A1 PIPERIDINE OR 8-AZA-BICYCLO(3.2.1)OCT-3-YL DERIVATIVES USEFUL AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY (ESPECIALLY CCR5) AstraZeneca AB (SE) 2004-12-29 EP disclosed
EP-1448525-A1 NOVEL PIPERIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORS AstraZeneca AB (SE) 2004-08-25 EP disclosed
WO-2004018425-A1 N-4-PIPERIDINYL COMPOUNDS AS CCR5 MODULATORS ASTRAZENECA AB (SE) 2004-03-04 WO disclosed
WO-2003080574-A1 PIPERIDINE OR 8-AZA-BICYCLO[3.2.1]OCT-3-YL DERIVATIVES USEFUL AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY (ESPECIALLY CCR5) ASTRAZENECA AB (SE) 2003-10-02 WO disclosed
WO-2003042178-A1 NOVEL PIPERIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORS ASTRAZENECA AB (SE) 2003-05-22 WO disclosed